miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6. (Q39025625)
Jump to navigation
Jump to search
scientific article published on 28 April 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6. |
scientific article published on 28 April 2014 |
Statements
1 reference
miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6. (English)
1 reference
Xiaolan Zhu
1 reference
Yuefeng Li
1 reference
Chanjuan Xie
1 reference
Xinming Yin
1 reference
Yueqin Liu
1 reference
Yuan Cao
1 reference
Yue Fang
1 reference
Xin Lin
1 reference
Yao Xu
1 reference
Wenlin Xu
1 reference
Huiling Shen
1 reference
Jian Wen
1 reference
28 April 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference